Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Cruciate Ligament Diagnosis Treatment Companies

Diagnosis and treatment of cruciate ligament injuries, particularly referring to the anterior cruciate ligament (ACL) in the knee, involve a combination of medical professionals, diagnostic tools, and therapeutic interventions. While there may not be specific companies solely dedicated to ACL diagnosis and treatment, various companies contribute to this field by providing medical devices, imaging technologies, and rehabilitation solutions.

Cruciate Ligament Diagnosis & Treatment Key Companies

Latest Cruciate Ligament Diagnosis and Treatment Companies Update

Jan 2023: The FDA has approved the ACL TightRope implant for pediatric patients, according to a recent announcement from Arthrex, a leader in lightweight surgical technologies. The first and only anterior cruciate ligament (ACL) fixation device approved for use in children is the TightRope implant, which is utilized in the surgical cure of orthopedic injuries. Alongside leading orthopedic surgeons, Arthrex developed all-epiphyseal and transphyseal procedures and instrumentation for ACL surgery. The FDA-approved additional indications and the addition of pediatric and young adolescent-specific hardware and implants to Arthrex's knee ligament array constitute a significant advance over current treatment choices for this high-risk group of athletes.

Jan 2023: Leading global provider of medical technology, Zimmer Biomet Holdings, Inc., declared that it has finalized an agreement to pay $155 million at closing and up to more than $120 million, contingent upon meeting future regulatory and commercial objectives over three years, for the acquisition of Embody, Inc., a privately held medical device business focused on soft tissue healing. In 2023, the purchase is expected to be marginally dilutive to adjusted profits per share and contribute positively to overall revenue growth. The acquisition includes Embody's whole line of collagen-based biointegrative solutions, such as the biointegrative implant TAPESTRY® for tendon recuperation and TAPESTRY® RC, which was among the first arthroscopic implant devices for rotator cuff repair to support healing in the most difficult orthopedic soft tissue injuries.List of Cruciate Ligament Diagnosis and Treatment Key companies in the market

Stryker Corporation

Arthrex, Inc.

Zimmer Biomet

DePuy Synthes, Inc.

CONMED Corporation

Smith & Nephew plc.

DJO Global Inc.

Breg, Inc.

Bauerfeind AG

Cruciate Ligament Diagnosis Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.